Approach to Hyponatremia
Initial Assessment and Classification
Begin by confirming true hypotonic hyponatremia: check serum osmolality (<275 mOsm/kg) and exclude pseudohyponatremia from hyperglycemia by correcting sodium (add 1.6 mEq/L for each 100 mg/dL glucose >100 mg/dL). 1, 2
Obtain the following initial workup 1:
- Serum and urine osmolality to confirm hypotonic hyponatremia 1
- Urine sodium concentration to differentiate causes (spot urine sodium <30 mmol/L suggests hypovolemia with 71-100% positive predictive value for saline responsiveness) 1
- Serum uric acid (<4 mg/dL has 73-100% positive predictive value for SIADH) 1
- Thyroid function (TSH) and cortisol to exclude endocrine causes 1, 2
- Serum creatinine to assess renal function 1
Assess extracellular fluid volume status through physical examination 1, 2:
- Hypovolemic signs: orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins 1
- Euvolemic signs: no edema, normal blood pressure, moist mucous membranes 1
- Hypervolemic signs: peripheral edema, ascites, jugular venous distention 1, 2
Note that physical examination alone has poor accuracy (sensitivity 41.1%, specificity 80%) for volume assessment 1
Treatment Based on Symptom Severity
Severe Symptomatic Hyponatremia (Medical Emergency)
For patients with severe symptoms (seizures, coma, altered mental status, confusion), immediately administer 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours or until severe symptoms resolve. 1, 2, 3, 4
- Give 100 mL boluses of 3% saline over 10 minutes, repeatable up to three times at 10-minute intervals until symptoms improve 1, 2
- Monitor serum sodium every 2 hours during initial correction 1, 2
- Total correction must not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 2, 3, 4
- Consider ICU admission for close monitoring 1
Mild to Moderate Symptomatic or Asymptomatic Hyponatremia
Treatment depends on volume status and underlying cause (see below) 1, 2
Treatment Based on Volume Status
Hypovolemic Hyponatremia
Discontinue diuretics immediately and administer isotonic (0.9%) saline for volume repletion. 1, 2
- Urine sodium <30 mmol/L predicts good response to saline (71-100% positive predictive value) 1
- Once euvolemic, reassess and treat underlying cause 1
- Maximum correction: 8 mmol/L in 24 hours 1, 2
Euvolemic Hyponatremia (SIADH)
Fluid restriction to 1 L/day is the cornerstone of treatment for SIADH. 1, 2, 3
If no response to fluid restriction 1, 2:
- Add oral sodium chloride 100 mEq three times daily 1
- Consider urea (effective but poor palatability) 3
- Consider vasopressin receptor antagonists (vaptans) such as tolvaptan 15 mg once daily, titrating to 30-60 mg as needed 1, 5, 3
Common pitfall: Using fluid restriction in cerebral salt wasting (CSW) worsens outcomes—CSW requires volume and sodium replacement, not restriction 1
Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
Implement fluid restriction to 1-1.5 L/day for serum sodium <125 mmol/L and treat the underlying condition. 1, 2, 4
- Discontinue diuretics temporarily if sodium <125 mmol/L 1
- Consider albumin infusion in cirrhotic patients 1, 2
- Avoid hypertonic saline unless life-threatening symptoms are present, as it worsens edema and ascites 1
- For persistent severe hyponatremia despite fluid restriction, consider tolvaptan with caution (higher risk of GI bleeding in cirrhosis: 10% vs 2% placebo) 1, 5
Correction Rate Guidelines by Severity
The single most important principle: never exceed 8 mmol/L correction in 24 hours. 1, 2, 3, 4
Standard Correction Rates 1, 2:
- Serum sodium 126-135 mmol/L: Continue current therapy with close electrolyte monitoring 1
- Serum sodium 121-125 mmol/L: More cautious approach; consider stopping diuretics 1
- Serum sodium <120 mmol/L: Stop diuretics immediately; implement severe fluid restriction or volume expansion as appropriate 1, 2
High-Risk Patients Requiring Slower Correction (4-6 mmol/L per day, maximum 8 mmol/L in 24 hours) 1, 2:
- Advanced liver disease 1, 2
- Alcoholism 1, 2
- Malnutrition 1, 2
- Prior encephalopathy 1
- Severe hyponatremia (<120 mmol/L) 1
Rationale: These patients have higher risk of osmotic demyelination syndrome, which can cause dysarthria, dysphagia, oculomotor dysfunction, quadriparesis, or death, typically occurring 2-7 days after rapid correction 1
Special Considerations for Neurosurgical Patients
In neurosurgical patients, distinguish between SIADH and cerebral salt wasting (CSW), as treatment approaches are opposite. 1
SIADH characteristics 1:
- Euvolemic state
- Urine sodium >20-40 mmol/L
- Urine osmolality >300 mOsm/kg
- Treatment: Fluid restriction to 1 L/day 1
Cerebral Salt Wasting characteristics 1:
- True hypovolemia (CVP <6 cm H₂O)
- Urine sodium >20 mmol/L despite volume depletion
- Evidence of extracellular volume depletion
- Treatment: Volume and sodium replacement with isotonic or hypertonic saline, NOT fluid restriction 1
- For severe symptoms: 3% hypertonic saline plus fludrocortisone in ICU 1
Critical pitfall: Fluid restriction in CSW worsens outcomes 1
In subarachnoid hemorrhage patients at risk of vasospasm: Do not use fluid restriction; consider fludrocortisone or hydrocortisone to prevent natriuresis 1
Management of Overcorrection
If sodium correction exceeds 8 mmol/L in 24 hours, immediately intervene to prevent osmotic demyelination syndrome. 1, 2
- Immediately discontinue current fluids and switch to D5W (5% dextrose in water) 1, 2
- Consider administering desmopressin to slow or reverse the rapid rise 1, 2
- Target: bring total 24-hour correction to no more than 8 mmol/L from starting point 1
Monitoring During Treatment
Severe symptoms 1, 2:
- Check serum sodium every 2 hours during initial correction 1, 2
- After symptom resolution, check every 4 hours 1
Mild symptoms or asymptomatic 1, 2:
Watch for signs of osmotic demyelination syndrome 1:
- Dysarthria, dysphagia, oculomotor dysfunction, quadriparesis
- Typically occurs 2-7 days after rapid correction 1
Common Pitfalls to Avoid
- Overly rapid correction (>8 mmol/L in 24 hours) leading to osmotic demyelination syndrome 1, 2, 3
- Inadequate monitoring during active correction 1
- Using fluid restriction in CSW (worsens outcomes) 1
- Failing to recognize and treat the underlying cause 1
- Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 1
- Ignoring mild hyponatremia (130-135 mmol/L)—even mild hyponatremia increases fall risk (21% vs 5%) and mortality (60-fold increase with sodium <130 mmol/L) 1, 3